Broadridge Financial Solutions filings document a NYSE-listed financial technology company with common stock registered under the Exchange Act. The company’s Form 8-K disclosures cover operating and financial results, Regulation FD investor presentations, dividend declarations, board composition changes, annual meeting voting results, and other material events.
Broadridge’s regulatory record also includes capital-structure and securities disclosures tied to its public equity and debt activity, along with governance matters such as director elections, executive compensation votes, auditor ratification, committee assignments, and risk-factor language accompanying investor materials and earnings releases.
Broadridge Financial Solutions reported that Corporate VP and CHRO Richard John Stingi acquired a new stock option award. He received stock options covering 10,039 shares of the company’s stock as a grant, recorded at a transaction price of $0.0000 per option. These stock options vest in equal installments over four years, beginning on March 5, 2027, which means the award becomes fully exercisable gradually rather than all at once.
Broadridge Financial Solutions president Christopher John Perry received a grant of 51,047 stock options on March 5, 2026. These options carry an exercise price of $0.00 per share, meaning they were granted at no cost to him.
The stock options vest in equal installments over four years, beginning on March 5, 2027. This award increases his directly held derivative securities to 51,047 options, aligning his compensation with the company’s long-term performance.
Jarkowski Hope M. reported acquisition or exercise transactions in this Form 4 filing.
Broadridge Financial Solutions' Chief Legal Officer Hope M. Jarkowski received a grant of stock options covering 20,872 shares of common stock. These options were awarded at a stated price of $0.00 per option as part of her compensation.
The stock options vest in equal installments over four years, beginning on March 5, 2027. This staged vesting structure is designed to align the executive’s incentives with the company’s longer-term performance and encourage continued service over the full vesting period.
Gokey Timothy C reported acquisition or exercise transactions in this Form 4 filing.
Broadridge Financial Solutions CEO Timothy C. Gokey received a grant of 170,667 stock options. These options are a right to buy Broadridge shares and are reported as a derivative security.
The stock options vest in equal installments over four years, beginning on March 5, 2027, aligning long-term compensation with the company’s future performance.
Ghei Ashima reported acquisition or exercise transactions in this Form 4 filing.
Broadridge Financial Solutions, Inc. interim CFO Ashima Ghei received a grant of stock options covering 23,254 shares of the company’s common stock. These options were awarded on March 5, 2026 as a form of equity compensation.
According to the disclosure, the stock options vest in equal installments over four years, beginning on March 5, 2027. This structure is designed to tie the executive’s potential future benefit to continued service and the company’s long-term performance.
Broadridge Financial Solutions reported an insider equity award for Co-President ICS Douglas Richard DeSchutter. He received a grant of stock options covering 25,977 shares on March 5, 2026, recorded at a transaction price of $0.00 because it is an award, not a market purchase.
All 25,977 stock options are held as direct ownership and this award increased his derivative holdings to 25,977 options. According to the footnote, the options will vest in equal installments over 4 years beginning March 5, 2027, meaning the right to exercise builds gradually over time.
Broadridge Financial Solutions reported that Corporate VP Carey Thomas P acquired a new stock option award. On March 5, 2026, Thomas received 25,977 stock options, giving the right to buy Broadridge shares. Following this grant, Thomas held 25,977 stock options in total.
According to the footnote, these options vest equally over four years, beginning on March 5, 2027, meaning portions of the award become exercisable each year over that period.
Broadridge Financial Solutions director equity grants: On March 5, 2026, director Patricia Ann Mosconi acquired 1,786 stock options and 420 shares of common stock through equity awards.
The common stock reflects Deferred Stock Units granted under Broadridge's 2018 Omnibus Award Plan, which represent an equivalent number of Broadridge common shares. These Deferred Stock Units vest in full upon grant and will be settled in shares of common stock when the director separates from service. The stock options vest immediately upon grant.
Broadridge Financial Solutions, Inc. announced that its Board of Directors has declared a quarterly cash dividend of $0.975 per share. The dividend will be paid on April 8, 2026 to stockholders of record at the close of business on March 16, 2026.
The company described itself as a global technology leader serving the financial services industry, supporting governance, communications, and trading operations across global markets.
Broadridge Financial Solutions director Robert N. Duelks reported indirect movements of company Common Stock tied to family trusts. A bona fide gift moved 17,000 shares on March 2, 2026 from the Mary E. Duelks 2007 Revocable Trust to the Mary E. Duelks 2020 Irrevocable Trust at a stated price of $0.00 per share. As of that date, filings show 20,815 shares held directly, plus indirect holdings of 4,474 shares through BOMAR II LLC and 8,853 shares through the Robert N. Duelks 2007 Revocable Trust.